Market›Health Care›Biotechnology›Biotechnology
ASCENTAGE PHARMA GRO ADR

AAPG

$23.95Jan 24, 2025 – Apr 24, 2026
Health CareBiotechnology$2.42B
MVM
+$0.0M

Every news event mapped to its market reaction — 33 events, 15 months of data. No predictions, just what happened.

PositiveNegativeNo data· Dot size = magnitude · Scroll to zoom · Drag to pan
Hover to inspect

Want the full written briefing?

The chart shows what moved — the briefing shows why. Sourced, dated, no hot takes.

Subscribe on Substack →

News Events

DateReturnCategorySourceHeadline
2025-03-27+20.1%earningsSeeking AlphaAscentage Pharma Group International GAAP EPS of -$0.18, revenue of $134.3M
2026-04-01+13.6%earningsMarketBeatAscentage Pharma Group International (NASDAQ:AAPG) Sees Large Volume Increase - Here's Why - MarketBeat
2026-04-22-13.5%newsSimply Wall St.Global Growth Companies With High Insider Ownership In April 2026
2026-04-22-13.5%newsGlobeNewswireAscentage Pharma to Present Data from Multiple Trials, Including Three Rapid Oral Presentations, at ASCO 2026
2026-03-27+10.7%newsMT NewswiresAscentage Pharma Builds Momentum With 2 'Potential Blockbuster' Drugs, Oppenheimer Says
2026-03-27+10.7%earningsSeeking AlphaAscentage Pharma Group International 2025 Q4 - Results - Earnings Call Presentation
2025-09-03-9.1%newsSeeking AlphaAscentage Pharma Group International (AAPG) Presents At Citi's Biopharma Back To School Conference Transcript
2026-03-26+6.4%legalMT NewswiresSector Update: Health Care Stocks Lean Lower Premarket Thursday
2026-03-26+6.4%legalMT NewswiresSector Update: Health Care
2026-03-26+6.4%earningsMT NewswiresAscentage Pharma's 2025 Loss Widens, Revenue Falls
2026-03-26+6.4%earningsSeeking AlphaAscentage Pharma Group International (AAPG) Q4 2025 Earnings Call Transcript
2026-03-26+6.4%earningsSeeking AlphaAscentage Pharma Group International GAAP EPS of $0.50 beats by $1.66
2026-04-20-5.5%newsSimply Wall St.Global Growth Companies With High Insider Ownership
2026-04-20-5.5%analystGlobeNewswireAscentage Pharma to Present Four Promising Preclinical Studies Demonstrating the Potential of Combination Therapies at American Association for Cancer Research (AACR) 2026 Annual Meeting
2026-04-20-5.5%earningsMarketBeatAscentage Pharma Group International (NASDAQ:AAPG) Shares Gap Down - What's Next? - MarketBeat
2026-01-15-4.7%newsSeeking AlphaAscentage Pharma Group International (AAPG) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
2026-02-10+4.5%newsThe Globe and MailAscentage Pharma to Present at Guggenheim Biotech Summit as Late-Stage Oncology Pipeline Expands - The Globe and Mail
2026-04-14+4.4%earningsMarketBeatAscentage Pharma Group International - Unsponsored ADR (NASDAQ:AAPG) Short Interest Update - MarketBeat
2026-04-17-4.0%newsSimply Wall St.Global Insights Into 3 Growth Stocks With High Insider Ownership
2026-04-10-2.6%earningsMarketBeatAscentage Pharma Group International (NASDAQ:AAPG) Shares Gap Down - What's Next? - MarketBeat
2026-01-19-1.8%newsSeeking AlphaAscentage Pharma Group International (AAPG) Presents at 44th Annual J.P. Morgan Healthcare Conference - Slideshow
2026-02-12-1.7%legalSeeking AlphaAscentage Pharma Group International (AAPG) Presents at Guggenheim Securities Emerging Outlook: Biotech Summit 2026 Transcript
2026-03-30+1.0%earningsMarketBeatAscentage Pharma Group International (NASDAQ:AAPG) Shares Gap Up - Here's What Happened - MarketBeat
2026-03-30+1.0%earningsMarketBeatAscentage Pharma Group International - Unsponsored ADR (NASDAQ:AAPG) Receives Consensus Recommendation of "Buy" from Analysts - MarketBeat
2025-07-08-0.9%executiveSeeking AlphaAscentage Pharma appoints Veet Misra as CFO
2025-09-01-0.8%newsYahoo FinanceHere's Why Ascentage Pharma Group International - Unsponsored ADR (AAPG) Is a Great 'Buy the Bottom' Stock Now - Yahoo Finance
2025-02-07+0.8%newsSeeking AlphaAscentage Pharma announces underwriters partially exercise option to purchase additional ADS
2026-04-06-0.5%earningsMarketBeatAscentage Pharma Group International (NASDAQ:AAPG) Shares Gap Up - Should You Buy? - MarketBeat
2026-04-26—earningsMarketBeatAscentage Pharma Group International - Unsponsored ADR (NASDAQ:AAPG) Short Interest Down 51.1% in April - MarketBeat
2026-04-24—analystMT NewswiresDeutsche Bank Initiates Coverage on Ascentage Pharma Group Internat With Buy Rating, $40 Price Target
2026-04-24—newsChartMillAAPG Stock Price, Quote & Chart | ASCENTAGE PHARMA GR-ADR (NASDAQ:AAPG) - ChartMill
2026-04-24—earningsMarketBeatAscentage Pharma Group International - Unsponsored ADR (NASDAQ:AAPG) Receives Consensus Recommendation of "Buy" from Analysts - MarketBeat
2026-04-24—earningsMarketBeatAscentage Pharma Group International (NASDAQ:AAPG) Sees Large Volume Increase - Here's Why - MarketBeat
tickerdossier.comtickerdossier.substack.com